Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial

International Journal of Antimicrobial Agents(2021)

引用 51|浏览12
暂无评分
摘要
•Artemisinin-piperaquine, as a fourth-generation artemisinin-based combination therapy, had a therapeutic effect on COVID-19•Artemisinin-piperaquine treatment could significantly shorten the time to reach undetectable SARS-CoV-2•This is a new option therapy for COVID-19
更多
查看译文
关键词
Artemisinin,Piperaquine,COVID-19,Antimalarial,SARS-CoV-2
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要